AUG 19, 2026 · JOURNAL ARTICLE
CRISPR-Cas9 and the Future of Ocular Retinal Therapy: A New Era for Ocular Disease
Current Advances in Medicine.
This is a narrative review synthesizing preclinical and early-stage trial evidence without new primary data, raising mechanistic potential rather than demonstrating clinical efficacy in humans.
Study details
DesignNarrative review